Oceania Healthcare (ASX:OCA) - CEO, Brent Pattison
CEO, Brent Pattison
Source: Oceania Healthcare
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Oceania Healthcare (OCA) has closed its non-underwritten, NZ$20 million (roughly A$18.49 million) retail offer oversubscribed
  • The retail offer was well supported by shareholders, with Oceania receiving applications totalling around NZ$50 million (around A$42.2 million)
  • The new shares will be issued at NZ$1.27 (about A$1.17), a 2.5 per cent discount to the five-day volume-weighted average market price of Oceania shares
  • Settlement of the offer is expected to occur tomorrow
  • Oceania Healthcare shares last traded at $1.21 cents on April 14

Oceania Healthcare (OCA) has closed its non-underwritten retail offer oversubscribed.

Oceania Healthcare is a leading provider of healthcare services in New Zealand.

The NZ$20 million (approximately A$18.49 million) offer was well supported by shareholders, with Oceania receiving applications totalling around NZ$50 million (around A$42.2 million). Scaling and the return of any surplus application amounts will be carried out in accordance with the terms of the retail offer.  

The offer was part of Oceania’s equity raising, under which Oceania also undertook a fully underwritten NZ$80 million (roughly A$74 million) placement of new shares to institutional shareholders in New Zealand, Australia and other jurisdictions.

Under the retail offer, eligible existing shareholders could each subscribe for up to NZ$50,000 (around A$46,220) worth of new Oceania shares. Over 5,000 Oceania shareholders applied under the retail offer, with an average application size of NZ$9,600 (approximately A$8,894).

The new shares will be issued at NZ$1.27 (approximately A$1.17), a 2.5 per cent discount to the five-day volume-weighted average market price of Oceania shares.

Settlement of the offer is expected to occur tomorrow, with new shares ranking equally in all respects to existing ordinary shares.

Oceania Healthcare shares last traded at $1.21 cents on April 14.

OCA by the numbers
More From The Market Herald

" Cann Group (ASX:CAN) granted GMP licence by TGA

Cann Group (ASX:CAN) receives a GMP licence from the Therapeutic Goods Administration (TGA) to manufacture therapeutic…
1st Group (ASX:1ST) - Managing Director, Klaus Bartosch

" 1st Group (ASX:1ST) shares rise on Visionflex acquisition

Digital health company 1st Group (ASX:1ST) was up as much as 25 per cent on the…
Atomo Diagnostics (ASX:AT1) - Managing Director, John Kelly

" Atomo Diagnostics (ASX:AT1) sees growth in cash receipts as demand for rapid antigen tests soars

Atomo Diagnostics (ASX:AT1) sees growth in cash receipts as demand for rapid antigen tests soars
Argenica Therapeutics (ASX:AGN) - CEO, Dr Liz Dallimore

" Argenica Therapeutics (ASX:AGN) determines safe starting dose level for ARG-007

Argenica Therapeutics (ASX:AGN) determines safe starting dose level from toxicology and genotoxicity studies